Phase II Randomized Study of the Efficacy and Safety of Hypofractionated Stereotactic Radiotherapy and 5FU or Capecitabine With and Without Zometa in Patients With Locally Advanced Pancreatic Cancer
Summary
The purpose of this phase II trial is to study how well hypofractionated stereotactic body radiation therapy and fluorouracil or capecitabine with or without zoledronic acid work in treating patients with pancreatic cancer that has spread from where it started to nearby tissue or lymph nodes.
General Information
NCT#: NCT03073785
Study ID: 552-16
Trial Phase: Phase II
Trial Sponsor: University of Nebraska
Therapies Used in This Trial: Fluorouracil, Capecitabine, Stereotactic body radiotherapy (SBRT), Zoledronic Acid